+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Genome Editing Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

  • PDF Icon

    Report

  • 105 Pages
  • January 2024
  • Region: Global
  • Prof Research
  • ID: 5593862

Quick Summary:

In the rapidly evolving industry of Genome Editing, staying ahead of trends, influencing factors, and key player movements is crucial. Our comprehensive market research report provides a detailed analysis, guiding you in making insightful business decisions. We've observed, verified, and compiled data from 2018 to the present date, and extended our understanding of market tendencies to predict scenarios up to 2028.

Our in-depth report further distinguishes between critical regions—North America, South America, Asia & Pacific, Europe and MEA, outlining the volatile supply-demand matrices and prominent players in each. Alongside, we provide unprecedented insights into competitor profiles, including their main business information, SWOT analysis, sales volume, revenue, price, gross margin, and market share. Enhance your strategic decisions using our report, and maintain your competitive edge in this diverse marketplace.

Gaining insights into the application segments right from cell line engineering to plant genetic engineering and the types segments like CRISPR, TALEN, and ZFN is now possible with our expansive report. Top companies like Bio-Rad Laboratories Inc., Origene Technologies, Transposagen, Takara Bios, and Astra Zeneca have been evaluated in this report, providing unmatched exposure to the Genome Editing industry landscape. Dive into our comprehensive report, and power your business strategy today.

This report describes the global market size of Genome Editing from 2019 to 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029.

For the geography segment, regional supply, demand, major players, price is presented from 2019 to 2029. This report cover following regions:
  • North America
  • South America
  • Asia & Pacific
  • Europe
  • MEA
The key countries for each region are also included such as the United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For the competitor segment, the report includes global key players of Genome Editing as well as some small players. The information for each competitor include:
  • Company Profile
  • Business Information
  • SWOT Analysis
  • Revenue, Gross Margin and Market Share

Types Segment:

  • First-generation nuclease-based genome editing
  • Next-generation genome editing

Companies Covered:

  • Beam Therapeutics Inc.
  • Verve Therapeutics Inc.
  • Sangamo Therapeutics Inc.
  • Precision BioSciences Inc.
  • Cellectis S.A.
  • bluebird bio Inc.
  • Arbor Biotech
  • Chroma Medicine Inc.
  • Mammoth Biosciences
  • Scribe Therapeutics
  • etc.
Base Year: 2024
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 COVID-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Genome Editing Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Genome Editing Market in North America (2019-2029)
8.1 Genome Editing Market Size
8.2 Genome Editing Market by End Use
8.3 Competition by Players/Suppliers
8.4 Genome Editing Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Genome Editing Market in South America (2019-2029)
9.1 Genome Editing Market Size
9.2 Genome Editing Market by End Use
9.3 Competition by Players/Suppliers
9.4 Genome Editing Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Genome Editing Market in Asia & Pacific (2019-2029)
10.1 Genome Editing Market Size
10.2 Genome Editing Market by End Use
10.3 Competition by Players/Suppliers
10.4 Genome Editing Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Genome Editing Market in Europe (2019-2029)
11.1 Genome Editing Market Size
11.2 Genome Editing Market by End Use
11.3 Competition by Players/Suppliers
11.4 Genome Editing Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Genome Editing Market in MEA (2019-2029)
12.1 Genome Editing Market Size
12.2 Genome Editing Market by End Use
12.3 Competition by Players/Suppliers
12.4 Genome Editing Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Genome Editing Market (2019-2024)
13.1 Genome Editing Market Size
13.2 Genome Editing Market by End Use
13.3 Competition by Players/Suppliers
13.4 Genome Editing Market Size by Type
Chapter 14 Global Genome Editing Market Forecast (2024-2029)
14.1 Genome Editing Market Size Forecast
14.2 Genome Editing Application Forecast
14.3 Competition by Players/Suppliers
14.4 Genome Editing Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Beam Therapeutics Inc.
15.1.1 Company Profile
15.1.2 Main Business and Genome Editing Information
15.1.3 SWOT Analysis of Beam Therapeutics Inc.
215.1.4 Beam Therapeutics Inc. Genome Editing Revenue, Gross Margin and Market Share (2019-2024)
15.2 Verve Therapeutics Inc.
15.2.1 Company Profile
15.2.2 Main Business and Genome Editing Information
15.2.3 SWOT Analysis of Verve Therapeutics Inc.
215.2.4 Verve Therapeutics Inc. Genome Editing Revenue, Gross Margin and Market Share (2019-2024)
15.3 Sangamo Therapeutics Inc.
15.3.1 Company Profile
15.3.2 Main Business and Genome Editing Information
15.3.3 SWOT Analysis of Sangamo Therapeutics Inc.
215.3.4 Sangamo Therapeutics Inc. Genome Editing Revenue, Gross Margin and Market Share (2019-2024)
15.4 Precision BioSciences Inc.
15.4.1 Company Profile
15.4.2 Main Business and Genome Editing Information
15.4.3 SWOT Analysis of Precision BioSciences Inc.
215.4.4 Precision BioSciences Inc. Genome Editing Revenue, Gross Margin and Market Share (2019-2024)
15.5 Cellectis S.A.
15.5.1 Company Profile
15.5.2 Main Business and Genome Editing Information
15.5.3 SWOT Analysis of Cellectis S.A.
215.5.4 Cellectis S.A. Genome Editing Revenue, Gross Margin and Market Share (2019-2024)
15.6 bluebird bio Inc.
15.6.1 Company Profile
15.6.2 Main Business and Genome Editing Information
15.6.3 SWOT Analysis of bluebird bio Inc.
215.6.4 bluebird bio Inc. Genome Editing Revenue, Gross Margin and Market Share (2019-2024)
15.7 Arbor Biotech
15.7.1 Company Profile
15.7.2 Main Business and Genome Editing Information
15.7.3 SWOT Analysis of Arbor Biotech
215.7.4 Arbor Biotech Genome Editing Revenue, Gross Margin and Market Share (2019-2024)
15.8 Chroma Medicine Inc.
15.8.1 Company Profile
15.8.2 Main Business and Genome Editing Information
15.8.3 SWOT Analysis of Chroma Medicine Inc.
215.8.4 Chroma Medicine Inc. Genome Editing Revenue, Gross Margin and Market Share (2019-2024)
15.9 Mammoth Biosciences
15.9.1 Company Profile
15.9.2 Main Business and Genome Editing Information
15.9.3 SWOT Analysis of Mammoth Biosciences
215.9.4 Mammoth Biosciences Genome Editing Revenue, Gross Margin and Market Share (2019-2024)
15.10 Scribe Therapeutics
15.10.1 Company Profile
15.10.2 Main Business and Genome Editing Information
15.10.3 SWOT Analysis of Scribe Therapeutics
215.10.4 Scribe Therapeutics Genome Editing Revenue, Gross Margin and Market Share (2019-2024)
List of Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Genome Editing Report
Table Data Sources of Genome Editing Report
Table Major Assumptions of Genome Editing Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Genome Editing Picture
Table Genome Editing Classification
Table Genome Editing Applications
Table Drivers of Genome Editing Market
Table Restraints of Genome Editing Market
Table Opportunities of Genome Editing Market
Table Threats of Genome Editing Market
Table COVID-19 Impact For Genome Editing Market
Table Raw Materials Suppliers
Table Different Production Methods of Genome Editing
Table Cost Structure Analysis of Genome Editing
Table Key End Users
Table Latest News of Genome Editing Market
Table Merger and Acquisition
Table Planned/Future Project of Genome Editing Market
Table Policy of Genome Editing Market
Table 2019-2029 North America Genome Editing Market Size
Figure 2019-2029 North America Genome Editing Market Size and CAGR
Table 2019-2029 North America Genome Editing Market Size by Application
Table 2019-2024 North America Genome Editing Key Players Revenue
Table 2019-2024 North America Genome Editing Key Players Market Share
Table 2019-2029 North America Genome Editing Market Size by Type
Table 2019-2029 United States Genome Editing Market Size
Table 2019-2029 Canada Genome Editing Market Size
Table 2019-2029 Mexico Genome Editing Market Size
Table 2019-2029 South America Genome Editing Market Size
Figure 2019-2029 South America Genome Editing Market Size and CAGR
Table 2019-2029 South America Genome Editing Market Size by Application
Table 2019-2024 South America Genome Editing Key Players Revenue
Table 2019-2024 South America Genome Editing Key Players Market Share
Table 2019-2029 South America Genome Editing Market Size by Type
Table 2019-2029 Brazil Genome Editing Market Size
Table 2019-2029 Argentina Genome Editing Market Size
Table 2019-2029 Chile Genome Editing Market Size
Table 2019-2029 Peru Genome Editing Market Size
Table 2019-2029 Asia & Pacific Genome Editing Market Size
Figure 2019-2029 Asia & Pacific Genome Editing Market Size and CAGR
Table 2019-2029 Asia & Pacific Genome Editing Market Size by Application
Table 2019-2024 Asia & Pacific Genome Editing Key Players Revenue
Table 2019-2024 Asia & Pacific Genome Editing Key Players Market Share
Table 2019-2029 Asia & Pacific Genome Editing Market Size by Type
Table 2019-2029 China Genome Editing Market Size
Table 2019-2029 India Genome Editing Market Size
Table 2019-2029 Japan Genome Editing Market Size
Table 2019-2029 South Korea Genome Editing Market Size
Table 2019-2029 Southeast Asia Genome Editing Market Size
Table 2019-2029 Australia Genome Editing Market Size
Table 2019-2029 Europe Genome Editing Market Size
Figure 2019-2029 Europe Genome Editing Market Size and CAGR
Table 2019-2029 Europe Genome Editing Market Size by Application
Table 2019-2024 Europe Genome Editing Key Players Revenue
Table 2019-2024 Europe Genome Editing Key Players Market Share
Table 2019-2029 Europe Genome Editing Market Size by Type
Table 2019-2029 Germany Genome Editing Market Size
Table 2019-2029 France Genome Editing Market Size
Table 2019-2029 United Kingdom Genome Editing Market Size
Table 2019-2029 Italy Genome Editing Market Size
Table 2019-2029 Spain Genome Editing Market Size
Table 2019-2029 Belgium Genome Editing Market Size
Table 2019-2029 Netherlands Genome Editing Market Size
Table 2019-2029 Austria Genome Editing Market Size
Table 2019-2029 Poland Genome Editing Market Size
Table 2019-2029 Russia Genome Editing Market Size
Table 2019-2029 MEA Genome Editing Market Size
Figure 2019-2029 MEA Genome Editing Market Size and CAGR
Table 2019-2029 MEA Genome Editing Market Size by Application
Table 2019-2024 MEA Genome Editing Key Players Revenue
Table 2019-2024 MEA Genome Editing Key Players Market Share
Table 2019-2029 MEA Genome Editing Market Size by Type
Table 2019-2029 Egypt Genome Editing Market Size
Table 2019-2029 Israel Genome Editing Market Size
Table 2019-2029 South Africa Genome Editing Market Size
Table 2019-2029 Gulf Cooperation Council Countries Genome Editing Market Size
Table 2019-2029 Turkey Genome Editing Market Size
Table 2019-2024 Global Genome Editing Market Size by Region
Table 2019-2024 Global Genome Editing Market Size Share by Region
Table 2019-2024 Global Genome Editing Market Size by Application
Table 2019-2024 Global Genome Editing Market Share by Application
Table 2019-2024 Global Genome Editing Key Vendors Revenue
Figure 2019-2024 Global Genome Editing Market Size and Growth Rate
Table 2019-2024 Global Genome Editing Key Vendors Market Share
Table 2019-2024 Global Genome Editing Market Size by Type
Table 2019-2024 Global Genome Editing Market Share by Type
Table 2024-2029 Global Genome Editing Market Size by Region
Table 2024-2029 Global Genome Editing Market Size Share by Region
Table 2024-2029 Global Genome Editing Market Size by Application
Table 2024-2029 Global Genome Editing Market Share by Application
Table 2024-2029 Global Genome Editing Key Vendors Revenue
Figure 2024-2029 Global Genome Editing Market Size and Growth Rate
Table 2024-2029 Global Genome Editing Key Vendors Market Share
Table 2024-2029 Global Genome Editing Market Size by Type
Table 2024-2029 Genome Editing Global Market Share by Type

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Beam Therapeutics Inc.
  • Verve Therapeutics Inc.
  • Sangamo Therapeutics Inc.
  • Precision BioSciences Inc.
  • Cellectis S.A.
  • bluebird bio Inc.
  • Arbor Biotech
  • Chroma Medicine Inc.
  • Mammoth Biosciences
  • Scribe Therapeutics
  • Tessera Therapeutics
  • Tome Biosciences
  • Tune Therapeutics Inc.
  • Metagenomi Technologies LLC

Methodology

Loading
LOADING...